Literature DB >> 7862873

Raised corticosterone in the rat after exposure to the elevated plus-maze.

S E File1, H Zangrossi, F L Sanders, P S Mabbutt.   

Abstract

Rats given one or two 5-min trials in the elevated plus-maze had plasma corticosterone concentrations significantly higher than the home cage control group and there was no sign of habituation in the group given two trials. In rats given two plus-maze trials the corticosterone responses were significantly higher in the group given 10-min rather than 5-min trials. A previous experience of cat odour (1 week earlier) has no effect on the plasma corticosterone response, but did have an anxiogenic effect that could be detected by a decrease in the percentage of time spent on the open arms of the plus-maze. The results are discussed with reference to the nature of anxiety generated by trials 1 and 2 and by the trial duration in the plus-maze, and with respect to dissociation between behavioural and endocrinological measures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862873     DOI: 10.1007/bf02245237

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Trial 2 in the elevated plus-maze: a different form of fear?

Authors:  S E File; H Zangrossi; M Viana; F G Graeff
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  The rat corticosterone response: habituation and modification by chlordiazepoxide.

Authors:  S E File
Journal:  Physiol Behav       Date:  1982-07

3.  The use of a plus-maze to measure anxiety in the mouse.

Authors:  R G Lister
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?

Authors:  S E File; H Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor.

Authors:  S E File; H Zangrossi; F L Sanders; P S Mabbutt
Journal:  Physiol Behav       Date:  1993-12

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  The effects of ethanol and diazepam on reactions to predatory odors.

Authors:  R J Blanchard; D C Blanchard; S M Weiss; S Meyer
Journal:  Pharmacol Biochem Behav       Date:  1990-04       Impact factor: 3.533

8.  Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor.

Authors:  H Zangrossi; S E File
Journal:  Brain Res Bull       Date:  1992 Sep-Oct       Impact factor: 4.077

9.  Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience.

Authors:  R J Rodgers; C Lee; J K Shepherd
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors.

Authors:  M A Critchley; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

View more
  25 in total

1.  GABA(A) ρ receptor mechanisms in the rat amygdala and its role in the modulation of fear and anxiety.

Authors:  Candy Flores-Gracia; Avril Nuche-Bricaire; Minerva Crespo-Ramírez; Ricardo Miledi; Kjell Fuxe; Miguel Pérez de la Mora
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

2.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

3.  Anxiety: a potential predictor of vulnerability to the initiation of ethanol self-administration in rats.

Authors:  R Spanagel; A Montkowski; K Allingham; T Stöhr; M Shoaib; F Holsboer; R Landgraf
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Ovarian steroids modify the behavioral and neurochemical responses of the central benzodiazepine receptor.

Authors:  D Bitran; J A Dowd
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

5.  Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?

Authors:  C T Wotjak; M Kubota; G Liebsch; A Montkowski; F Holsboer; I Neumann; R Landgraf
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

6.  Blockade of the endovanilloid receptor, TRPV1, and of the endocannabinoid enzyme, FAAH, within the nucleus accumbens shell elicits anxiolytic-like effects in male rats.

Authors:  Thibaut R Pardo-García; Nadira Yusif-Rodriguez; Guillermo Yudowski; Carmen S Maldonado-Vlaar
Journal:  Neurosci Lett       Date:  2020-05-16       Impact factor: 3.046

7.  The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

8.  Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats.

Authors:  Akiyoshi Saitoh; Yuji Yoshikawa; Kenji Onodera; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

9.  Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats.

Authors:  M D S Lapiz-Bluhm; C O Bondi; J Doyen; G A Rodriguez; T Bédard-Arana; D A Morilak
Journal:  J Neuroendocrinol       Date:  2008-07-30       Impact factor: 3.627

10.  Handling of adolescent rats improves learning and memory and decreases anxiety.

Authors:  Rafaela Costa; Mariana L Tamascia; Marie D Nogueira; Dulce E Casarini; Fernanda K Marcondes
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.